1. Home
  2. TARA vs CEE Comparison

TARA vs CEE Comparison

Compare TARA & CEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARA
  • CEE
  • Stock Information
  • Founded
  • TARA N/A
  • CEE 1990
  • Country
  • TARA United States
  • CEE Germany
  • Employees
  • TARA N/A
  • CEE N/A
  • Industry
  • TARA Biotechnology: Biological Products (No Diagnostic Substances)
  • CEE Finance Companies
  • Sector
  • TARA Health Care
  • CEE Finance
  • Exchange
  • TARA Nasdaq
  • CEE Nasdaq
  • Market Cap
  • TARA 118.1M
  • CEE 105.5M
  • IPO Year
  • TARA N/A
  • CEE N/A
  • Fundamental
  • Price
  • TARA $3.03
  • CEE $15.95
  • Analyst Decision
  • TARA Strong Buy
  • CEE
  • Analyst Count
  • TARA 6
  • CEE 0
  • Target Price
  • TARA $19.80
  • CEE N/A
  • AVG Volume (30 Days)
  • TARA 148.6K
  • CEE 22.0K
  • Earning Date
  • TARA 11-11-2025
  • CEE 01-01-0001
  • Dividend Yield
  • TARA N/A
  • CEE 3.86%
  • EPS Growth
  • TARA N/A
  • CEE N/A
  • EPS
  • TARA N/A
  • CEE N/A
  • Revenue
  • TARA N/A
  • CEE N/A
  • Revenue This Year
  • TARA N/A
  • CEE N/A
  • Revenue Next Year
  • TARA N/A
  • CEE N/A
  • P/E Ratio
  • TARA N/A
  • CEE N/A
  • Revenue Growth
  • TARA N/A
  • CEE N/A
  • 52 Week Low
  • TARA $1.60
  • CEE $7.80
  • 52 Week High
  • TARA $10.48
  • CEE $10.32
  • Technical
  • Relative Strength Index (RSI)
  • TARA 43.85
  • CEE 43.17
  • Support Level
  • TARA $3.05
  • CEE $15.60
  • Resistance Level
  • TARA $3.20
  • CEE $16.33
  • Average True Range (ATR)
  • TARA 0.13
  • CEE 0.45
  • MACD
  • TARA -0.01
  • CEE -0.06
  • Stochastic Oscillator
  • TARA 3.33
  • CEE 47.98

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

About CEE The Central and Eastern Europe Fund Inc. (The)

CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.

Share on Social Networks: